<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32005848</PMID><DateCompleted><Year>2020</Year><Month>11</Month><Day>17</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Jan</Month><Day>31</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Repeated intramuscular transplantations of hUCB-MSCs improves motor function and survival in the SOD1 G<sup>93</sup>A mice through activation of AMPK.</ArticleTitle><Pagination><StartPage>1572</StartPage><MedlinePgn>1572</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1572</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-020-58221-1</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that is characterized by loss of motor neurons and degeneration of neuromuscular junctions. To improve disease progression, previous studies have suggested many options that have shown beneficial effects in diseases, especially stem cell therapy. In this study, we used repeated intramuscular transplantation of human umbilical cord blood-derived mesenchymal stem cells (hUCB-MSCs) and observed positive effects on muscle atrophy and oxidative stress. In an in vivo study, motor function, body weight and survival rate were assessed, and skeletal muscle tissues were analyzed by western blotting and immunohistochemistry. After intramuscular transplantation, the hUCB-MSCs survived within the skeletal muscle for at least 1 week. Transplantation ameliorated muscle atrophy and the rate of neuromuscular degeneration in skeletal muscle through reductions in intracellular ROS levels. Both&#xa0;expression of skeletal muscle atrophy markers, muscle atrophy F-box (MAFbx)/atrogin1 and muscle RING finger 1 (MuRF1), were also reduced; however, the reductions were not significant. Moreover, transplantation of hUCB-MSCs improved protein synthesis and inhibited the iNOS/NO signaling pathway through AMPK activation. Our results suggest that repeated intramuscular transplantation of hUCB-MSCs can be a practical option for stem cell therapy for ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kook</LastName><ForeName>Myung Geun</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Adult Stem Cell Research Center and Research Institute for Veterinary Science, College of Veterinary Medicine, Seoul National University, Seoul, 08826, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>SeungEun</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Adult Stem Cell Research Center and Research Institute for Veterinary Science, College of Veterinary Medicine, Seoul National University, Seoul, 08826, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>Nari</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Adult Stem Cell Research Center and Research Institute for Veterinary Science, College of Veterinary Medicine, Seoul National University, Seoul, 08826, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kong</LastName><ForeName>Dasom</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Adult Stem Cell Research Center and Research Institute for Veterinary Science, College of Veterinary Medicine, Seoul National University, Seoul, 08826, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Da-Hyun</ForeName><Initials>DH</Initials><AffiliationInfo><Affiliation>Adult Stem Cell Research Center and Research Institute for Veterinary Science, College of Veterinary Medicine, Seoul National University, Seoul, 08826, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Min-Soo</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Adult Stem Cell Research Center and Research Institute for Veterinary Science, College of Veterinary Medicine, Seoul National University, Seoul, 08826, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Hyun Kyoung</ForeName><Initials>HK</Initials><AffiliationInfo><Affiliation>Adult Stem Cell Research Center and Research Institute for Veterinary Science, College of Veterinary Medicine, Seoul National University, Seoul, 08826, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Soon Won</ForeName><Initials>SW</Initials><Identifier Source="ORCID">0000-0001-8642-6093</Identifier><AffiliationInfo><Affiliation>Adult Stem Cell Research Center and Research Institute for Veterinary Science, College of Veterinary Medicine, Seoul National University, Seoul, 08826, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Kyung-Sun</ForeName><Initials>KS</Initials><AffiliationInfo><Affiliation>Adult Stem Cell Research Center and Research Institute for Veterinary Science, College of Veterinary Medicine, Seoul National University, Seoul, 08826, Republic of Korea. kangpub@snu.ac.kr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>01</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017382">Reactive Oxygen Species</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.14.13.39</RegistryNumber><NameOfSubstance UI="D052247">Nitric Oxide Synthase Type II</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D036101" MajorTopicYN="N">Cord Blood Stem Cell Transplantation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007273" MajorTopicYN="N">Injections, Intramuscular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020935" MajorTopicYN="Y">MAP Kinase Signaling System</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045164" MajorTopicYN="N">Mesenchymal Stem Cell Transplantation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009048" MajorTopicYN="Y">Motor Skills</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009133" MajorTopicYN="N">Muscular Atrophy</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D032446" MajorTopicYN="N">Myoblasts</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D052247" MajorTopicYN="N">Nitric Oxide Synthase Type II</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017382" MajorTopicYN="N">Reactive Oxygen Species</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>7</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>1</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>2</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>2</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32005848</ArticleId><ArticleId IdType="pmc">PMC6994691</ArticleId><ArticleId IdType="doi">10.1038/s41598-020-58221-1</ArticleId><ArticleId IdType="pii">10.1038/s41598-020-58221-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Riva N, Agosta F, Lunetta C, Filippi M, Quattrini A. Recent advances in amyotrophic lateral sclerosis. J. Neurol. 2016;263:1241&#x2013;1254. doi: 10.1007/s00415-016-8091-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-016-8091-6</ArticleId><ArticleId IdType="pmc">PMC4893385</ArticleId><ArticleId IdType="pubmed">27025851</ArticleId></ArticleIdList></Reference><Reference><Citation>Lunn JS, Sakowski SA, Feldman EL. Concise review: Stem cell therapies for amyotrophic lateral sclerosis: recent advances and prospects for the future. Stem Cell. 2014;32:1099&#x2013;1109. doi: 10.1002/stem.1628.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.1628</ArticleId><ArticleId IdType="pmc">PMC4225704</ArticleId><ArticleId IdType="pubmed">24448926</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Fry CME, Walker CL. Carboxyl-terminal modulator protein regulates Akt signaling during skeletal muscle atrophy in vitro and a mouse model of amyotrophic lateral sclerosis. Sci. Rep. 2019;9:3920. doi: 10.1038/s41598-019-40553-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-40553-2</ArticleId><ArticleId IdType="pmc">PMC6408440</ArticleId><ArticleId IdType="pubmed">30850672</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao Y, et al. ROS-related mitochondrial dysfunction in skeletal muscle of an ALS mouse model during the disease progression. Pharmacol. Res. 2018;138:25&#x2013;36. doi: 10.1016/j.phrs.2018.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2018.09.008</ArticleId><ArticleId IdType="pmc">PMC6263743</ArticleId><ArticleId IdType="pubmed">30236524</ArticleId></ArticleIdList></Reference><Reference><Citation>Forostyak S, et al. Intrathecal delivery of mesenchymal stromal cells protects the structure of altered perineuronal nets in SOD1 rats and amends the course of ALS. Stem Cell. 2014;32:3163&#x2013;3172. doi: 10.1002/stem.1812.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.1812</ArticleId><ArticleId IdType="pmc">PMC4321196</ArticleId><ArticleId IdType="pubmed">25113670</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancuso R, et al. Resveratrol improves motoneuron function and extends survival in SOD1(G93A) ALS mice. Neurotherapeutics. 2014;11:419&#x2013;432. doi: 10.1007/s13311-013-0253-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-013-0253-y</ArticleId><ArticleId IdType="pmc">PMC3996124</ArticleId><ArticleId IdType="pubmed">24414863</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh KW, et al. Repeated Intrathecal Mesenchymal Stem Cells for Amyotrophic Lateral Sclerosis. Ann. Neurol. 2018;84:361&#x2013;373. doi: 10.1002/ana.25302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25302</ArticleId><ArticleId IdType="pmc">PMC6175096</ArticleId><ArticleId IdType="pubmed">30048006</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters, S. et al. The TgF-beta system as a Potential Pathogenic Player in Disease Modulation of amyotrophic lateral sclerosis. Front Neurol, 8, 10.3389/fneur.2017.00669 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5736544</ArticleId><ArticleId IdType="pubmed">29326641</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez, D. et al. ALS skeletal muscle shows enhanced TGF-beta signaling, fibrosis and induction of fibro/adipogenic progenitor markers. Plos One, 12, 10.1371/journal.pone.0177649 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5433732</ArticleId><ArticleId IdType="pubmed">28520806</ArticleId></ArticleIdList></Reference><Reference><Citation>Si, Y. et al. Transforming Growth Factor Beta (TGF-beta) Is a Muscle Biomarker of Disease Progression in ALS and Correlates with Smad Expression. Plos One, 10, 10.1371/journal.pone.0138425 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4574401</ArticleId><ArticleId IdType="pubmed">26375954</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrigo J, Rivera JC, Simon F, Cabrera D, Cabello-Verrugio C. Transforming growth factor type beta (TGF-beta) requires reactive oxygen species to induce skeletal muscle atrophy. Cell Signal. 2016;28:366&#x2013;376. doi: 10.1016/j.cellsig.2016.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellsig.2016.01.010</ArticleId><ArticleId IdType="pubmed">26825874</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim MA, et al. Reduced activity of AMP-activated protein kinase protects against genetic models of motor neuron disease. J. Neurosci. 2012;32:1123&#x2013;1141. doi: 10.1523/JNEUROSCI.6554-10.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.6554-10.2012</ArticleId><ArticleId IdType="pmc">PMC3742882</ArticleId><ArticleId IdType="pubmed">22262909</ArticleId></ArticleIdList></Reference><Reference><Citation>Perera, N. D. et al. Mutant TDP-43 Deregulates AMPK Activation by PP2A in ALS Models. Plos One, 9, 10.1371/journal.pone.0090449 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3942426</ArticleId><ArticleId IdType="pubmed">24595038</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu YJ, Lee LM, Lai HL, Chern Y. Aberrant activation of AMP-activated protein kinase contributes to the abnormal distribution of HuR in amyotrophic lateral sclerosis. FEBS Lett. 2015;589:432&#x2013;439. doi: 10.1016/j.febslet.2014.12.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2014.12.029</ArticleId><ArticleId IdType="pubmed">25592834</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu YJ, et al. Activation of AMP-activated protein kinase alpha1 mediates mislocalization of TDP-43 in amyotrophic lateral sclerosis. Hum. Mol. Genet. 2015;24:787&#x2013;801. doi: 10.1093/hmg/ddu497.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu497</ArticleId><ArticleId IdType="pubmed">25256353</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaneb, H. M., Sharp, P. S., Rahmani-Kondori, N. &amp; Wells, D. J. Metformin Treatment Has No Beneficial Effect in a Dose-Response Survival Study in the SOD1(G93A) Mouse Model of ALS and Is Harmful in Female Mice. Plos One, 6, 10.1371/journal.pone.0024189 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3164704</ArticleId><ArticleId IdType="pubmed">21909419</ArticleId></ArticleIdList></Reference><Reference><Citation>Coughlan KS, Mitchem MR, Hogg MC, Prehn JHM. &#x201c;Preconditioning&#x201d; with latrepirdine, an adenosine 5 &#x2018;-monophosphate-activated protein kinase activator, delays amyotrophic lateral sclerosis progression in SOD1(G93A) mice. Neurobiol. Aging. 2015;36:1140&#x2013;1150. doi: 10.1016/j.neurobiolaging.2014.09.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.09.022</ArticleId><ArticleId IdType="pubmed">25443289</ArticleId></ArticleIdList></Reference><Reference><Citation>Samuel MA, et al. LKB1 and AMPK regulate synaptic remodeling in old age. Nat. Neurosci. 2014;17:1190&#x2013;1197. doi: 10.1038/nn.3772.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3772</ArticleId><ArticleId IdType="pmc">PMC5369022</ArticleId><ArticleId IdType="pubmed">25086610</ArticleId></ArticleIdList></Reference><Reference><Citation>Dial AG, Ng SY, Manta A, Ljubicic V. The Role of AMPK in Neuromuscular Biology and Disease. Trends Endocrinol. Metab. 2018;29:300&#x2013;312. doi: 10.1016/j.tem.2018.02.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tem.2018.02.010</ArticleId><ArticleId IdType="pubmed">29572064</ArticleId></ArticleIdList></Reference><Reference><Citation>Gugliandolo A, Bramanti P, Mazzon E. Mesenchymal Stem Cells: A Potential Therapeutic Approach for Amyotrophic Lateral Sclerosis? Stem Cell Int. 2019;2019:3675627. doi: 10.1155/2019/3675627.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/3675627</ArticleId><ArticleId IdType="pmc">PMC6431432</ArticleId><ArticleId IdType="pubmed">30956667</ArticleId></ArticleIdList></Reference><Reference><Citation>Rehorova, M. et al. A Combination of Intrathecal and Intramuscular Application of Human Mesenchymal Stem Cells Partly Reduces the Activation of Necroptosis in the Spinal Cord of SOD1(G93A) Rats. Stem Cells Transl Med, 10.1002/sctm.18-0223 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6525562</ArticleId><ArticleId IdType="pubmed">30802001</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrou P, et al. Safety and Clinical Effects of Mesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in Patients With Amyotrophic Lateral Sclerosis: Results of Phase 1/2 and 2a Clinical Trials. JAMA Neurol. 2016;73:337&#x2013;344. doi: 10.1001/jamaneurol.2015.4321.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2015.4321</ArticleId><ArticleId IdType="pubmed">26751635</ArticleId></ArticleIdList></Reference><Reference><Citation>Sykova E, et al. Transplantation of Mesenchymal Stromal Cells in Patients With Amyotrophic Lateral Sclerosis: Results of Phase I/IIa Clinical Trial. Cell Transpl. 2017;26:647&#x2013;658. doi: 10.3727/096368916X693716.</Citation><ArticleIdList><ArticleId IdType="doi">10.3727/096368916X693716</ArticleId><ArticleId IdType="pmc">PMC5661219</ArticleId><ArticleId IdType="pubmed">27938483</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrigo J, Simon F, Cabrera D, Cabello-Verrugio C. Angiotensin-(1-7) Prevents Skeletal Muscle Atrophy Induced by Transforming Growth Factor Type Beta (TGF-beta) via Mas Receptor Activation. Cell Physiol. Biochem. 2016;40:27&#x2013;38. doi: 10.1159/000452522.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000452522</ArticleId><ArticleId IdType="pubmed">27842312</ArticleId></ArticleIdList></Reference><Reference><Citation>Park CM, et al. Umbilical cord mesenchymal stem cell-conditioned media prevent muscle atrophy by suppressing muscle atrophy-related proteins and ROS generation. Vitro Cell Dev. Biol. Anim. 2016;52:68&#x2013;76. doi: 10.1007/s11626-015-9948-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11626-015-9948-1</ArticleId><ArticleId IdType="pubmed">26373864</ArticleId></ArticleIdList></Reference><Reference><Citation>Sriramulu S, et al. Concise Review on Clinical Applications of Conditioned Medium Derived from Human Umbilical Cord-Mesenchymal Stem Cells (UC-MSCs) Int. J. Hematol. Oncol. Stem Cell Res. 2018;12:230&#x2013;234.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6305261</ArticleId><ArticleId IdType="pubmed">30595826</ArticleId></ArticleIdList></Reference><Reference><Citation>Bak DH, et al. Antioxidant effect of human placenta hydrolysate against oxidative stress on muscle atrophy. J. Cell Physiol. 2019;234:1643&#x2013;1658. doi: 10.1002/jcp.27034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.27034</ArticleId><ArticleId IdType="pubmed">30132871</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrigo J, et al. Role of Oxidative Stress as Key Regulator of Muscle Wasting during Cachexia. Oxid. Med. Cell Longev. 2018;2018:2063179. doi: 10.1155/2018/2063179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/2063179</ArticleId><ArticleId IdType="pmc">PMC5896211</ArticleId><ArticleId IdType="pubmed">29785242</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollari E, Goldsteins G, Bart G, Koistinaho J, Giniatullin R. The role of oxidative stress in degeneration of the neuromuscular junction in amyotrophic lateral sclerosis. Front. Cell Neurosci. 2014;8:131. doi: 10.3389/fncel.2014.00131.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2014.00131</ArticleId><ArticleId IdType="pmc">PMC4026683</ArticleId><ArticleId IdType="pubmed">24860432</ArticleId></ArticleIdList></Reference><Reference><Citation>Ichim TE, et al. Mesenchymal stem cells as anti-inflammatories: implications for treatment of Duchenne muscular dystrophy. Cell Immunol. 2010;260:75&#x2013;82. doi: 10.1016/j.cellimm.2009.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellimm.2009.10.006</ArticleId><ArticleId IdType="pubmed">19917503</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki M, et al. Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS. Mol. Ther. 2008;16:2002&#x2013;2010. doi: 10.1038/mt.2008.197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mt.2008.197</ArticleId><ArticleId IdType="pmc">PMC2678899</ArticleId><ArticleId IdType="pubmed">18797452</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall, D. T. et al. The AMPK agonist 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR), but not metformin, prevents inflammation-associated cachectic muscle wasting. Embo Molecular Medicine, 10, 10.15252/emmm.201708307 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6034131</ArticleId><ArticleId IdType="pubmed">29844217</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma JF, et al. STAT3 promotes IFNgamma/TNFalpha-induced muscle wasting in an NF-kappaB-dependent and IL-6-independent manner. EMBO Mol. Med. 2017;9:622&#x2013;637. doi: 10.15252/emmm.201607052.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201607052</ArticleId><ArticleId IdType="pmc">PMC5412921</ArticleId><ArticleId IdType="pubmed">28264935</ArticleId></ArticleIdList></Reference><Reference><Citation>Cramer, Z. et al. eIF4A inhibition prevents the onset of cytokine-induced muscle wasting by blocking the STAT3 and iNOS pathways. Scientific Reports, 8, 10.1038/s41598-018-26625-9 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5976662</ArticleId><ArticleId IdType="pubmed">29849089</ArticleId></ArticleIdList></Reference><Reference><Citation>Powers SK, Ji LL, Kavazis AN, Jackson MJ. Reactive oxygen species: impact on skeletal muscle. Compr. Physiol. 2011;1:941&#x2013;969. doi: 10.1002/cphy.c100054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cphy.c100054</ArticleId><ArticleId IdType="pmc">PMC3893116</ArticleId><ArticleId IdType="pubmed">23737208</ArticleId></ArticleIdList></Reference><Reference><Citation>Schieber M, Chandel NS. ROS function in redox signaling and oxidative stress. Curr. Biol. 2014;24:R453&#x2013;462. doi: 10.1016/j.cub.2014.03.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2014.03.034</ArticleId><ArticleId IdType="pmc">PMC4055301</ArticleId><ArticleId IdType="pubmed">24845678</ArticleId></ArticleIdList></Reference><Reference><Citation>Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nat. 2000;408:239&#x2013;247. doi: 10.1038/35041687.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35041687</ArticleId><ArticleId IdType="pubmed">11089981</ArticleId></ArticleIdList></Reference><Reference><Citation>Ragusa RJ, Chow CK, Porter JD. Oxidative stress as a potential pathogenic mechanism in an animal model of Duchenne muscular dystrophy. Neuromuscul. Disord. 1997;7:379&#x2013;386. doi: 10.1016/S0960-8966(97)00096-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0960-8966(97)00096-5</ArticleId><ArticleId IdType="pubmed">9327402</ArticleId></ArticleIdList></Reference><Reference><Citation>Kook MG, et al. KCHO-1, a novel herbal anti-inflammatory compound, attenuates oxidative stress in an animal model of amyotrophic lateral sclerosis. J. Vet. Sci. 2017;18:487&#x2013;497. doi: 10.4142/jvs.2017.18.4.487.</Citation><ArticleIdList><ArticleId IdType="doi">10.4142/jvs.2017.18.4.487</ArticleId><ArticleId IdType="pmc">PMC5746442</ArticleId><ArticleId IdType="pubmed">28385005</ArticleId></ArticleIdList></Reference><Reference><Citation>Seo Y, et al. Human umbilical cord blood-derived mesenchymal stem cells protect against neuronal cell death and ameliorate motor deficits in Niemann Pick type C1 mice. Cell Transpl. 2011;20:1033&#x2013;1047. doi: 10.3727/096368910X545086.</Citation><ArticleIdList><ArticleId IdType="doi">10.3727/096368910X545086</ArticleId><ArticleId IdType="pubmed">21176403</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin TH, et al. Human umbilical cord blood-stem cells direct macrophage polarization and block inflammasome activation to alleviate rheumatoid arthritis. Cell Death Dis. 2016;7:e2524. doi: 10.1038/cddis.2016.442.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2016.442</ArticleId><ArticleId IdType="pmc">PMC5260999</ArticleId><ArticleId IdType="pubmed">28005072</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>